Login
$CLX
$110.17 +$0.00 (0.0%) After hours

$CLX SEC Filings

Filed On Filing
10 Nov 2026 SCHEDULE 13G
05 Nov 2026 Form 4: Breber Pierre R, Director

Bought 4,000 shares ($400K)

02 Nov 2026 10-Q
02 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

OAKLAND, Calif., Nov. 2, 2026 — The Clorox Company (NYSE: CLX) today reported results for the first quarter of fiscal year 2027, which ended Sept. 30, 2026.

29 Oct 2026 DEFINITIVE ADDITIONAL MATERIALS
29 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

OAKLAND, Calif., Oct. 29, 2026 — The Clorox Company (NYSE: CLX) today announced that its Board of Directors has appointed Fabian Garcia as CEO, effective Jan. 5, 2027, following a comprehensive search. Garcia will succeed Linda Rendle, w...

27 Oct 2026 SCHEDULE 13G/A
07 Oct 2026 Form 4: Rendle Linda J, Director

Received 29,352 shares as a grant or award ($2.36M) · Gave up 12,681 shares to cover exercise price or tax ($1.02M)

07 Oct 2026 Form 4: Peck Laurene E, VP - CAO & Corp Controller

Received 1,172 shares as a grant or award ($94.2K) · Gave up 369 shares to cover exercise price or tax ($29.7K)

07 Oct 2026 Form 4: Marriner Kirsten, EVP - Chief Admin Officer

Received 6,637 shares as a grant or award ($534K) · Gave up 4,093 shares to cover exercise price or tax ($329K)

07 Oct 2026 Form 4: Hyder Chris T, EVP-Chief Operating Officer

Received 4,191 shares as a grant or award ($337K) · Gave up 1,632 shares to cover exercise price or tax ($131K)

07 Oct 2026 Form 4: Hilt Angela C, EVP - Chief Legal Officer

Received 6,637 shares as a grant or award ($534K) · Gave up 4,647 shares to cover exercise price or tax ($374K)

07 Oct 2026 Form 4: Bellet Luc, EVP - Chief Financial Officer

Received 1,677 shares as a grant or award ($135K) · Gave up 1,611 shares to cover exercise price or tax ($130K)

07 Oct 2026 Form 4: Barton Nina, EVP-Chief Growth & Strategy Of

Gave up 1,106 shares to cover exercise price or tax ($88.9K)

07 Oct 2026 ARS
07 Oct 2026 DEFA14A
07 Oct 2026 Proxy statement: annual meeting on November 18, 2026

CEO pay $14.0M, up 5% · say-on-pay vote

02 Oct 2026 Form 4: Williams Christopher J, Director

Granted 276.2573 Deferred Stock Units · Granted 339.4642 Deferred Stock Units

02 Oct 2026 Form 4: Weiner Russell J, Director

Granted 226.7613 Deferred Stock Units · Granted 416.6152 Deferred Stock Units

02 Oct 2026 Form 4: Shattock Matthew J, Director

Granted 255.3782 Deferred Stock Units · Granted 648.0681 Deferred Stock Units

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support